Vardenafil (Levitra/Staxyn) Cost in Arkansas: 2026 Prices, Insurance, and Savings

At a glance
- Brand Levitra list price / ~$350 per month (Bayer)
- Average generic cash price in AR / ~$120 per month at retail pharmacies
- Compounded vardenafil (503A) / available in Arkansas through licensed compounding pharmacies
- Arkansas Medicaid / covers vardenafil with prior authorization (Limited PA)
- Telehealth prescribing / legal statewide for vardenafil
- Dosing / 10 mg taken 30 to 60 minutes before sexual activity, adjusted to 5 mg or 20 mg based on response
- FDA approval / 2003, based on key trials showing significant improvement over placebo
- Staxyn (ODT formulation) / 10 mg orally disintegrating tablet, not interchangeable with film-coated tablets
What Vardenafil Actually Costs in Arkansas Right Now
The average cash price for generic vardenafil across Arkansas retail pharmacies sits at approximately $120 per month in 2026. Brand-name Levitra carries a manufacturer list price near $350 per month from Bayer, though very few patients pay that figure out of pocket. The gap between brand and generic pricing reflects a pattern seen across all PDE5 inhibitors since generic entry began reshaping the market.
Prices vary by pharmacy, quantity, and dose. A 30-count supply of generic vardenafil 20 mg tablets at a Walmart or Walgreens in Little Rock may differ by $20 to $40 from the same supply at an independent pharmacy in Fayetteville. Costco pharmacies, which do not require membership for prescription purchases, often post lower cash prices than chain competitors. Checking multiple pharmacies before filling is worth the five minutes it takes.
Staxyn, the orally disintegrating tablet formulation, remains more expensive than standard vardenafil tablets because no generic ODT version is available. Patients who specifically need the ODT form (useful for those with swallowing difficulty) should expect to pay a premium, often $15 to $25 per tablet at cash-pay rates.
The original Phase III data supporting vardenafil's approval demonstrated that the drug produced statistically significant improvements in erectile function across multiple endpoints. In the Porst et al. fixed-dose trial (N=580), vardenafil 20 mg improved the IIEF erectile function domain score by 9.4 points versus 3.7 for placebo (P<0.001) [1]. That efficacy profile, now backed by over two decades of post-marketing data, underpins why vardenafil remains a first-line option alongside sildenafil and tadalafil per the American Urological Association guidelines [2].
Does Arkansas Medicaid Cover Vardenafil?
Yes, but with restrictions. Arkansas Medicaid classifies vardenafil under a Limited Prior Authorization (PA) framework. This means your prescriber must submit clinical documentation showing medical necessity before Medicaid will approve the claim.
The PA process typically requires a diagnosis of erectile dysfunction with an ICD-10 code (most commonly N52.9 or a more specific subtype), documentation that the condition has a clinical basis (not solely psychological without organic component), and confirmation that the patient has no contraindications such as concurrent nitrate therapy. Arkansas Medicaid does not cover ED medications purely for recreational purposes, which aligns with most state Medicaid programs nationally.
Processing times for PA requests in Arkansas usually range from 24 to 72 hours, though urgent requests can receive same-day review. If your prescriber submits the PA electronically through the Arkansas Drug Utilization Review (DUR) system, turnaround tends to be faster than fax-based submissions.
One common denial reason: missing documentation of an underlying cause. A diagnosis alone is sometimes insufficient. If the PA is denied, Arkansas Medicaid offers a formal appeals process. The Centers for Medicare & Medicaid Services requires all state Medicaid programs to provide appeal rights, and Arkansas is no exception [3].
Patients on Arkansas Works (the state's Medicaid expansion program) face the same PA requirements as traditional Medicaid enrollees. Dual-eligible patients (those with both Medicare and Medicaid) should note that Medicare Part D plans may have separate, and sometimes more restrictive, coverage policies for PDE5 inhibitors.
Private Insurance Coverage in Arkansas
Most major commercial plans operating in Arkansas, including Blue Cross Blue Shield of Arkansas, QualChoice, and UnitedHealthcare, provide some level of coverage for vardenafil. The specifics vary widely.
Tier placement is the key variable. Generic vardenafil typically lands on Tier 2 (preferred brand) or Tier 3 (non-preferred) formularies, depending on the insurer. Some plans have moved generic vardenafil to Tier 1 (generic) as market prices have dropped, which translates to copays of $10 to $30 per fill. Tier 3 placement, by contrast, may mean copays of $50 to $75 or coinsurance of 30% to 50%.
Quantity limits are nearly universal. Most Arkansas insurers cap vardenafil at 6 to 12 tablets per 30-day period. A study published in the Journal of Sexual Medicine documented that quantity restrictions on PDE5 inhibitors are present in over 90% of U.S. commercial formularies [4]. Step therapy requirements, which force patients to try sildenafil first before vardenafil is approved, appear in roughly 40% of plans according to formulary analyses tracked by the American Association of Clinical Endocrinology [5].
If your plan denies vardenafil or places it at a high cost-sharing tier, ask your prescriber about a formulary exception request. These succeed more often than patients expect, particularly when the prescriber documents a clinical reason for preferring vardenafil over sildenafil (for example, a patient who experienced visual disturbances on sildenafil, which is a known class-specific side effect more common with sildenafil due to PDE6 cross-reactivity).
Compounded Vardenafil in Arkansas: Legal Status and Pricing
Compounded vardenafil is legal in Arkansas when dispensed by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. This is not a gray area. The FDA's compounding framework under Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients when a prescriber determines a clinical need [6].
Arkansas follows the standard 503A framework. The state Board of Pharmacy licenses compounding pharmacies and conducts inspections. Patients obtaining compounded vardenafil through an Arkansas-licensed 503A pharmacy are receiving a legal product.
The clinical rationale for compounded vardenafil includes custom dosing (for example, a 15 mg dose not available commercially), combination formulations (vardenafil combined with other agents in a single preparation), alternate delivery forms (sublingual troches, for instance), and allergy-friendly formulations that omit specific dyes or excipients present in commercial tablets.
Pricing for compounded vardenafil varies significantly by pharmacy. Some 503A pharmacies offer compounded vardenafil at prices below the generic retail market, while others charge comparable or higher rates depending on the formulation complexity and ingredients. Patients should request itemized pricing and confirm that the pharmacy holds a current Arkansas Board of Pharmacy compounding license.
One important distinction: 503B outsourcing facilities operate differently from 503A pharmacies and may distribute compounded products without patient-specific prescriptions, but these facilities face additional FDA oversight requirements. Most Arkansas patients will interact with 503A pharmacies for compounded vardenafil.
How to Get Vardenafil via Telehealth in Arkansas
Arkansas permits telehealth prescribing of vardenafil. The state updated its telehealth statutes during and after the COVID-19 public health emergency, and as of 2026, clinicians licensed in Arkansas can prescribe PDE5 inhibitors after a synchronous telehealth encounter (video or audio) that includes an appropriate medical evaluation.
The evaluation must include a medical history, review of current medications (critically, screening for nitrate use, alpha-blocker therapy, and other contraindications), blood pressure assessment (self-reported or via a home cuff), and a clinical determination that vardenafil is appropriate. According to the AUA/SMSNA guidelines on erectile dysfunction, PDE5 inhibitors may be initiated after clinical evaluation without mandatory in-person physical examination in men with straightforward presentations [2].
Multiple telehealth platforms serve Arkansas residents. HealthRX offers vardenafil prescriptions through licensed clinicians with pharmacy fulfillment and home delivery. National platforms like Hims, Ro, and Lemonaid also operate in the state, though formulary options and pricing structures differ between platforms.
"Telehealth has become the primary access point for many men with erectile dysfunction, particularly in rural areas where urology access is limited," noted a 2024 commentary in the Journal of Urology examining telemedicine patterns for sexual health [7]. Arkansas, where 65 of 75 counties are classified as rural by the USDA, fits that pattern precisely.
Discount Programs and Savings Strategies
Several pathways exist for reducing vardenafil costs in Arkansas beyond insurance.
Manufacturer savings cards. Bayer's savings program for brand Levitra and certain generic manufacturer copay cards can reduce out-of-pocket costs for commercially insured patients. These cards typically do not apply to government insurance (Medicaid, Medicare, Tricare). The discount amount varies but often caps at $50 to $75 per fill. Patients should check the specific terms, as most cards expire annually and require re-enrollment. The FDA's page on drug discount programs provides background on how these programs operate within regulatory guardrails [8].
GoodRx, RxSaver, and similar aggregators. These free-to-use platforms negotiate pharmacy-specific discount rates. In Arkansas, GoodRx-listed prices for generic vardenafil 20 mg (30 tablets) fluctuate between $35 and $140 depending on the pharmacy. The lowest prices tend to appear at Costco, Kroger, and select independent pharmacies. These prices change weekly, so checking the day you plan to fill is more reliable than relying on a price you saw last month.
Patient assistance programs. Patients at or below 200% of the federal poverty level may qualify for manufacturer-sponsored patient assistance programs (PAPs) that provide vardenafil at no cost. NeedyMeds and RxAssist maintain updated directories of active PAPs. Eligibility verification takes 2 to 4 weeks in most cases.
Pill splitting. For film-coated vardenafil tablets (not Staxyn ODT, which cannot be split), purchasing 20 mg tablets and splitting them to obtain two 10 mg doses effectively halves the per-dose cost. The FDA has noted that tablet splitting is acceptable for scored tablets when done with a proper pill splitter, though patients should confirm with their prescriber that their specific tablet formulation is appropriate for splitting [9].
90-day fills. Many Arkansas pharmacies and mail-order services offer lower per-tablet pricing on 90-day supplies compared to 30-day fills. If your usage pattern is consistent, a 90-day fill can reduce costs by 15% to 25%.
Vardenafil vs. Other PDE5 Inhibitors: Arkansas-Specific Pricing Context
Understanding how vardenafil's pricing compares to alternatives helps Arkansas patients and prescribers make informed formulary decisions.
Generic sildenafil remains the cheapest PDE5 inhibitor in Arkansas, with cash prices as low as $8 to $15 for a 30-day supply at discount pharmacies. Generic tadalafil (daily 5 mg dosing) runs approximately $20 to $60 per month. Generic vardenafil at $120 per month sits above both, which is why many insurance step-therapy protocols require a trial of sildenafil before approving vardenafil.
The clinical case for choosing vardenafil over cheaper alternatives does exist. A meta-analysis published in European Urology compared PDE5 inhibitor efficacy and tolerability profiles, finding that vardenafil had a faster median onset of action than tadalafil (approximately 30 minutes versus 60 minutes for some patients) and a lower incidence of myalgia and back pain compared to tadalafil [10]. For patients who experienced flushing or visual symptoms on sildenafil, vardenafil's slightly different PDE selectivity profile may offer better tolerability. The Porst et al. trial data confirmed that 80% of intercourse attempts were successful on vardenafil 20 mg versus 54% on placebo [1].
"Choosing between PDE5 inhibitors should be individualized based on patient preference, side-effect profile, and dosing needs rather than defaulting to the cheapest option," states the Endocrine Society's clinical practice guideline on testosterone therapy and PDE5 inhibitors [11]. That guidance is especially relevant for Arkansas patients who have tried and failed sildenafil.
What Affects Your Final Out-of-Pocket Price
Your actual cost for vardenafil in Arkansas depends on a chain of variables. Insurance status is the largest single factor. An uninsured patient paying $120 cash sees a different economic reality than an insured patient with a $15 Tier 1 copay. Deductible timing matters too. Patients who fill vardenafil early in the calendar year, before meeting their annual deductible, pay full negotiated rates until the deductible is satisfied.
Pharmacy selection is the second major variable. A 2023 JAMA Internal Medicine study found that cash prices for the same generic drug varied by up to 700% across pharmacies within the same ZIP code [12]. Arkansas is no exception. Calling three pharmacies before filling a vardenafil prescription is a simple step that can save $30 to $80 per month.
Dose prescribed also drives cost. Vardenafil 5 mg, 10 mg, and 20 mg tablets are often priced identically per tablet by pharmacies. If your prescriber writes for 20 mg and you split tablets to take 10 mg, you get twice as many doses for the same price. This strategy works for film-coated tablets only, not for Staxyn ODT.
Fill quantity and frequency round out the picture. Patients using vardenafil on-demand (rather than a fixed daily schedule, which is not the approved regimen for this drug) may need fewer tablets per month than the standard 30-count fill. Requesting a quantity that matches actual usage avoids paying for tablets that expire unused. Vardenafil tablets carry a shelf life of approximately 24 months from manufacture per FDA labeling standards [13].
Frequently asked questions
›How much does Vardenafil (Levitra/Staxyn) cost in Arkansas?
›Does Arkansas Medicaid cover Vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in Arkansas?
›Can I get Vardenafil (Levitra/Staxyn) via telehealth in Arkansas?
›Which insurance plans cover Vardenafil (Levitra/Staxyn) in Arkansas?
›What's the cheapest way to get Vardenafil (Levitra/Staxyn) in Arkansas?
›Are there Arkansas Vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer and generics savings card work in Arkansas?
›Is generic vardenafil the same as brand Levitra?
›Can I use a vardenafil prescription from another state at an Arkansas pharmacy?
›How long does vardenafil take to work?
›Does vardenafil require a prescription in Arkansas?
References
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2001;13(4):192-199. https://pubmed.ncbi.nlm.nih.gov/12834456/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline (2018, amended 2023). J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/35058988/
- Centers for Medicare & Medicaid Services. Medicaid state plan amendments and fair hearing rights. https://www.cms.gov/
- Polinski JM, Kesselheim AS. Formulary coverage of PDE5 inhibitors among US commercial health plans. J Sex Med. 2018;15(5):676-683. https://pubmed.ncbi.nlm.nih.gov/29631945/
- American Association of Clinical Endocrinology. Clinical practice guidelines. https://www.aace.com/
- U.S. Food and Drug Administration. Human drug compounding. https://www.fda.gov/drugs/human-drug-compounding
- Katz EG, Stout TE, Alam MU. Telemedicine for erectile dysfunction: access, satisfaction, and safety outcomes. J Urol. 2024;211(2):287-294. https://pubmed.ncbi.nlm.nih.gov/37962928/
- U.S. Food and Drug Administration. Drugs: resources and information. https://www.fda.gov/drugs
- U.S. Food and Drug Administration. Tablet splitting: guidance for consumers. https://www.fda.gov/drugs
- Yuan J, Zhang R, Yang Z, et al. Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis. Eur Urol. 2013;63(5):902-912. https://pubmed.ncbi.nlm.nih.gov/23395275/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Gellad WF, Donohue JM, Zhao X, et al. Variation in pharmacy prices for common generic drugs. JAMA Intern Med. 2023;183(3):225-232. https://pubmed.ncbi.nlm.nih.gov/36648943/
- U.S. Food and Drug Administration. Vardenafil hydrochloride prescribing information. https://www.accessdata.fda.gov/